HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics
2025-05-02
The new initiative will focus on research using the beta-propiolactone vaccine platformContinue Reading
RFK Jr. to Change Vaccine Testing Rules
2025-05-02
FRIDAY, May 2, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to change how vaccines are tested in the U.S., a decision that could impact how quickly and widely vaccines are made available. The department said the new plan will promote transparency, butContinue Reading
Medetomidine, a Pet Sedative, Spreads in U.S. Illegal Drug Supply
2025-05-02
FRIDAY, May 2, 2025 (HealthDay News) — A sedative used in animals is showing up more often in illegal drugs and may be making opioid overdoses harder to treat, U.S. health officials warn. The drug, called medetomidine, is used by veterinarians to sedate pets. It’s similar to xylazine, another animalContinue Reading
FDA Commissioner: No Major Reorganization, Just Smart Reforms
2025-05-01
THURSDAY, May 1, 2025 (HealthDay News) — Dr. Marty Makary had just finished his last surgery at Johns Hopkins when he stepped into one of the most powerful roles in American public health. Now, as the new commissioner of the U.S. Food and Drug Administration (FDA), he’s wasting no timeContinue Reading
Epilepsy, Anxiety Meds Don’t Increase Suicide Risk
2025-05-01
THURSDAY, May 1, 2025 (HealthDay News) — A class of drugs used to treat epilepsy, nerve pain and anxiety do not appear to increase a person’s risk of self-harm, a major new study says. Gabapentinoids – which include gabapentin and pregabalin – have been associated with an increased risk ofContinue Reading
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
2025-04-29
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosaContinue Reading
United States Seeing Uptick in Whooping Cough Cases
2025-04-28
Number of cases this year has reached 8,485, twice as many as this time last yearContinue Reading
HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
2025-04-25
Government hopes to be prepared for possible bird flu pandemic or outbreak of other flu variationsContinue Reading
Novavax COVID Vaccine Moves Closer to Full FDA Approval
2025-04-25
FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax’s stock up more than 21% in early trading. It also helped ease fears that the decision had been delayedContinue Reading
FDA Approves Dupixent for Chronic Spontaneous Urticaria
2025-04-23
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatmentContinue Reading